V
Vijay Kumar Prajapati
Researcher at Central University of Rajasthan
Publications - 117
Citations - 3698
Vijay Kumar Prajapati is an academic researcher from Central University of Rajasthan. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 31, co-authored 93 publications receiving 2754 citations. Previous affiliations of Vijay Kumar Prajapati include Institute of Medical Sciences, Banaras Hindu University & Banaras Hindu University.
Papers
More filters
Journal ArticleDOI
MicroRNA mediated immune regulation of T helper cell differentiation and plasticity during visceral leishmaniasis infection: A computational approach
Peer ReviewDOI
Author response: Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
Hideo Imamura,Tim Downing,Tim Downing,Frederik Van den Broeck,Mandy Sanders,Suman Rijal,Shyam Sundar,An Mannaert,Manu Vanaerschot,Maya Berg,Géraldine De Muylder,Franck Dumetz,Bart Cuypers,Ilse Maes,Malgorzata A. Domagalska,Saskia Decuypere,Saskia Decuypere,Keshav Rai,Surendra Uranw,Narayan Raj Bhattarai,Basudha Khanal,Vijay Kumar Prajapati,Smriti Sharma,Olivia Stark,Gabriele Schönian,Harry P. de Koning,Luca Settimo,Luca Settimo,Benoit Vanhollebeke,Syamal Roy,Bart Ostyn,Marleen Boelaert,Louis Maes,Matthew Berriman,Jean-Claude Dujardin,Jean-Claude Dujardin,James Cotton +36 more
Journal ArticleDOI
Immunoglobulin interface redesigning to enhance lebrikizumab mediated immunomodulation of IL-13 hyper-response.
Vinita Sharma,Priya Chouhan,Rajan Kumar Pandey,Rupal Ojha,Veeranarayanan Surya Aathmanathan,Muthukalingan Krishnan,Vijay Kumar Prajapati +6 more
TL;DR: This work has attempted to modulate the lebrikizumab mAb to enhance its binding affinity towards IL-13, and these redesigned mAb could be used for potential treatment against IL- 13 associated diseased conditions.
Journal ArticleDOI
Editorial: Plant products for antiviral therapeutics
TL;DR: A strategic approach to combat viral infections would be to explore the OPEN ACCESS, which provides clues on the core structures as templates for the development of novel drug molecules.
Journal ArticleDOI
Neurodegeneration & imperfect ageing: Technological limitations and challenges?
Naveen Sundaria,Arun Upadhyay,Amit Prasad,Vijay Kumar Prajapati,Krishna Mohan Poluri,Amit Mishra +5 more
TL;DR: A detailed overview of current state-of-the-art techniques and advances in studying amyloid in the diseased brain is provided in this article. But, these studies face multiple technological challenges in utilizing available tools for detailed characterizations of the protein aggregates or amyloids and developing new techniques to understand the biology and pathology of proteopathies.